May 25, 2026
FDA-Cleared Indications for Use
Approved therapeutic applications for Stimel-03 and SSMD rehabilitation protocols.
Author: Motion Informatics
May 25, 2026
BioRhythmIQ™ Technology
Patient-specific EMG biofeedback that adapts therapy in real time.
May 25, 2026
SSMD for TBI Rehabilitation
Personalized stimulation and biofeedback to support motor, cognitive, and functional recovery.
May 25, 2026
SSMD After Vehicle Accidents
Targeted rehabilitation technology for restoring movement, confidence, and independence.
May 25, 2026
SSMD for Sports Injury Recovery
Advanced neuromuscular therapy to rebuild strength, coordination, and performance.
May 25, 2026
The Technologies Behind SSMD
An integrated FES, NMES, and biofeedback platform for patient-centered recovery.
May 25, 2026
SSMD for Next-Generation Rehabilitation
Personalized biofeedback-driven therapy designed for clinical and home recovery.
May 25, 2026
Stimel-03 for TBI Rehabilitation
Supporting motor recovery, neuroplasticity, and functional independence after brain injury.
May 25, 2026
Stimel-03 After Vehicle Accidents
Personalized neuromuscular therapy to restore movement and independence.
May 25, 2026
Stimel-03 for Sports Injury Recovery
Targeted muscle activation to support strength, mobility, and return to performance.